China Pharma Holdings Total Assets 2010-2023 | CPHI
China Pharma Holdings total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
China Pharma Holdings Annual Total Assets
(Millions of US $) |
| 2023 |
$16 |
| 2022 |
$18 |
| 2021 |
$23 |
| 2020 |
$21 |
| 2019 |
$22 |
| 2018 |
$45 |
| 2017 |
$60 |
| 2016 |
$79 |
| 2015 |
$97 |
| 2014 |
$121 |
| 2013 |
$158 |
| 2012 |
$163 |
| 2011 |
$156 |
| 2010 |
$132 |
| 2009 |
$101 |
China Pharma Holdings Quarterly Total Assets
(Millions of US $) |
| 2023-12-31 |
$16 |
| 2023-09-30 |
$15 |
| 2023-06-30 |
$16 |
| 2023-03-31 |
$17 |
| 2022-12-31 |
$18 |
| 2022-09-30 |
$16 |
| 2022-06-30 |
$18 |
| 2022-03-31 |
$21 |
| 2021-12-31 |
$23 |
| 2021-09-30 |
$18 |
| 2021-06-30 |
$20 |
| 2021-03-31 |
$20 |
| 2020-12-31 |
$21 |
| 2020-09-30 |
$21 |
| 2020-06-30 |
$23 |
| 2020-03-31 |
$22 |
| 2019-12-31 |
$22 |
| 2019-09-30 |
$40 |
| 2019-06-30 |
$43 |
| 2019-03-31 |
$45 |
| 2018-12-31 |
$45 |
| 2018-09-30 |
$53 |
| 2018-06-30 |
$58 |
| 2018-03-31 |
$62 |
| 2017-12-31 |
$60 |
| 2017-09-30 |
$75 |
| 2017-06-30 |
$77 |
| 2017-03-31 |
$78 |
| 2016-12-31 |
$79 |
| 2016-09-30 |
$87 |
| 2016-06-30 |
$92 |
| 2016-03-31 |
$97 |
| 2015-12-31 |
$97 |
| 2015-09-30 |
$109 |
| 2015-06-30 |
$121 |
| 2015-03-31 |
$118 |
| 2014-12-31 |
$121 |
| 2014-09-30 |
$141 |
| 2014-06-30 |
$146 |
| 2014-03-31 |
$154 |
| 2013-12-31 |
$158 |
| 2013-09-30 |
$162 |
| 2013-06-30 |
$159 |
| 2013-03-31 |
$159 |
| 2012-12-31 |
$163 |
| 2012-09-30 |
$166 |
| 2012-06-30 |
$165 |
| 2012-03-31 |
$164 |
| 2011-12-31 |
$156 |
| 2011-09-30 |
$151 |
| 2011-06-30 |
$143 |
| 2011-03-31 |
$137 |
| 2010-12-31 |
$132 |
| 2010-09-30 |
$122 |
| 2010-06-30 |
$116 |
| 2010-03-31 |
$108 |
| 2009-12-31 |
$101 |
| 2009-09-30 |
$95 |
| 2009-06-30 |
$86 |
| 2009-03-31 |
$80 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.005B |
$0.007B |
|
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
|
